STOCK TITAN

Merck Stock Price, News & Analysis

MKGAF OTC Link

Company Description

Merck (OTC Link: MKGAF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $55.3B.

MKGAF stock has gained 23.4% over the past year. Shares last traded at $163.78.

This page provides a comprehensive overview of MKGAF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$163.78
+0.04%
+0.07
Last updated: June 5, 2026 at 15:59
+23.37%
Performance 1 year
$55.3B

Merck (MKGAF) stock last traded at $163.78, up 0.04% from the previous close. Over the past 12 months, the stock has gained 23.4%. At a market capitalization of $55.3B, MKGAF is classified as a large-cap stock with approximately 434.8M shares outstanding.

Latest News

Merck has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all MKGAF news →

SEC Filings

No SEC filings available for MKGAF.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Merck (MKGAF) currently stands at 1.1 million shares, down 20.8% from the previous reporting period, representing 0.8% of the float. Over the past 12 months, short interest has increased by 82.9%. This relatively low short interest suggests limited bearish sentiment. With 695.4 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.

Days to Cover History

Last 12 Months

Days to cover for Merck (MKGAF) currently stands at 695.4 days, down 30.5% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 596.7% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 99.8 to 1000.0 days.

MKGAF Company Profile & Sector Positioning

Merck (MKGAF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.

Investors comparing MKGAF often look at related companies in the same sector, including Merck Kgaa (MKKGY), Takeda Pharmaceutical Co Ltd (TKPHF), GALDERMA GROUP AG (GALDY), Sandoz Group AG (SDZNY), and Ipsen Sa (IPSEY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MKGAF's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Merck (MKGAF)?

The current stock price of Merck (MKGAF) is $163.778 as of June 5, 2026.

What is the market cap of Merck (MKGAF)?

The market cap of Merck (MKGAF) is approximately 55.3B. Learn more about what market capitalization means .